U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H18O4S2
Molecular Weight 242.356
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFONETHYLMETHANE

SMILES

CCC(C)(S(=O)(=O)CC)S(=O)(=O)CC

InChI

InChIKey=LKACJLUUJRMGFK-UHFFFAOYSA-N
InChI=1S/C8H18O4S2/c1-5-8(4,13(9,10)6-2)14(11,12)7-3/h5-7H2,1-4H3

HIDE SMILES / InChI
Molecular Formula C8H18O4S2
Molecular Weight 242.356
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

1895
3
Doses

Doses

DosePopulationAdverse events​
1 g 1 times / day single, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: single
Dose: 1 g, 1 times / day
Co-administed with::
sulphonal(12 grains; 12 per 24 hr, during 4 to 5 weeks)
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
unhealthy, 39 years
n = 1
Health Status: unhealthy
Condition: chronic neurasthenia
Age Group: 39 years
Sex: M
Population Size: 1
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
Other AEs: Haematoporphyrinuria...
Other AEs:
Haematoporphyrinuria
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
1 g 1 times / day multiple, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: multiple
Dose: 1 g, 1 times / day
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
unhealthy, 44 years
n = 1
Health Status: unhealthy
Condition: nervousness, insomnia
Age Group: 44 years
Sex: F
Population Size: 1
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
Other AEs: Death...
Other AEs:
Death
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: depression, insomnia, gastric disorders
Age Group: 50 years
Sex: M
Population Size: 1
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Other AEs: Neuritis NOS, Haematoporphyrinuria...
Other AEs:
Neuritis NOS
Haematoporphyrinuria
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
1.3 g 1 times / day single, oral
Studied dose
Dose: 1.3 g, 1 times / day
Route: oral
Route: single
Dose: 1.3 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
unhealthy, adult
n = 1
Health Status: unhealthy
Condition: insomnia
Age Group: adult
Sex: M
Population Size: 1
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
Other AEs: Drowsiness...
Other AEs:
Drowsiness
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
AEs

AEs

AESignificanceDosePopulation
Haematoporphyrinuria
1 g 1 times / day single, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: single
Dose: 1 g, 1 times / day
Co-administed with::
sulphonal(12 grains; 12 per 24 hr, during 4 to 5 weeks)
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
unhealthy, 39 years
n = 1
Health Status: unhealthy
Condition: chronic neurasthenia
Age Group: 39 years
Sex: M
Population Size: 1
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
Death
1 g 1 times / day multiple, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: multiple
Dose: 1 g, 1 times / day
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
unhealthy, 44 years
n = 1
Health Status: unhealthy
Condition: nervousness, insomnia
Age Group: 44 years
Sex: F
Population Size: 1
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
Haematoporphyrinuria
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: depression, insomnia, gastric disorders
Age Group: 50 years
Sex: M
Population Size: 1
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Neuritis NOS
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
n = 1
Health Status: unhealthy
Condition: depression, insomnia, gastric disorders
Age Group: 50 years
Sex: M
Population Size: 1
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Drowsiness
1.3 g 1 times / day single, oral
Studied dose
Dose: 1.3 g, 1 times / day
Route: oral
Route: single
Dose: 1.3 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
unhealthy, adult
n = 1
Health Status: unhealthy
Condition: insomnia
Age Group: adult
Sex: M
Population Size: 1
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
Sourcing

Sourcing

Vendor/AggregatorIDURL
3B Scientific (Wuhan) Corp
3B3-022834
http://www.3bsc.com/index/pro_info.php?id=43910
ABI Chem
AC1L1MIU
ABI Chem
AC1Q2RZO
AHH Chemical co.,ltd
MT-30881
http://www.ahhchemical.com/product/MT-30881.html
Ambinter
Amb2221981
http://www.ambinter.com/reference/2221981
Chemieliva Pharmaceutical Co., Ltd
PBCM0818698
Debye Scientific
DS-007311
http://www.debyesci.com/cas_76-20-0.html
Enamine
BBV-40204292
LGC Standards
LGCFOR3149.00
https://www.lgcstandards.com/US/en/p/LGCFOR3149.00
LGC Standards
MM3149.00
https://www.lgcstandards.com/US/en/p/MM3149.00
MP Biomedicals
201338
NovoSeek
6433
Scientific Exchange
POD_54/0791
Smolecule
S544193
http://www.smolecule.com/products/s544193
THE BioTek
bt-282785
https://www.thebiotek.com/product/inhibitors/bt-282785
Tetrahedron
TS26899
TimTec
ST45025623
http://www.echemstore.com/st45025623-1-1-bis-ethylsulfonyl-1-methylpropane.html
ZINC
ZINC000000002115
http://zinc15.docking.org/substances/ZINC000000002115
mcule
MCULE-2164971606
https://mcule.com/MCULE-2164971606/
PubMed

PubMed

TitleDatePubMed
Study designs, duration, and choice of comparators including the use of placebo.
2002 Dec
Patents

Patents

JP1022898A
1
JP2000319357A
1
JP2002131536A
1
JP3094074B2
1
JP3630424B2
1
JPH07138347A
1
JPS06230735A
1
JPS63150224A
1
JPS63175327A
1
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:59:55 GMT 2023
Edited
by admin
on Fri Dec 15 15:59:55 GMT 2023
Record UNII
217727W28W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SULFONETHYLMETHANE
MI  
Common Name English
Methylsulfonal [WHO-DD]
Common Name English
NSC-3994
Code English
TRIONAL
Common Name English
SULFONETHYLMETHANE [MI]
Common Name English
METHYLSULPHONAL
Common Name English
DIETHYLSULFONMETHYLETHYLMETHANE
Common Name English
TRIONALON
Common Name English
METHYLSULFONAL
WHO-DD  
Common Name English
2,2-BIS(ETHYLSULFONYL)BUTANE
Systematic Name English
SULPHONETHYLMETHANE
Common Name English
Classification Tree Code System Code
DEA NO. 2605
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
NCI_THESAURUS C29756
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
200-942-4
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
CAS
76-20-0
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
ChEMBL
CHEMBL1990189
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
EVMPD
SUB14564MIG
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
EPA CompTox
DTXSID7046411
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
FDA UNII
217727W28W
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
PUBCHEM
6433
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
MERCK INDEX
m10358
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C74379
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
WIKIPEDIA
TRIONAL
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
SMS_ID
100000076220
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
DRUG CENTRAL
3570
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
NSC
3994
Created by admin on Fri Dec 15 15:59:55 GMT 2023 , Edited by admin on Fri Dec 15 15:59:55 GMT 2023
PRIMARY
Related Record Type Details
Structure of SULFONETHYLMETHANE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966